Congress

As our readers know, from both their own experience and the articles written on our website, drug pricing is a hot issue right…

The Senate Finance Committee has been conducting an investigation into Physician Owned Distributorships (PODs), leading…

The 2016 presidential race is fraught with hot-button issues, with each party and each candidate taking positions on…

There have been numerous media reports referencing dramatic drug price increases after the acquisition or merger of…

Deputy Attorney General Sally Q. Yates recently announced new guidance that the Department of Justice will focus…

Earlier this year, Valeant Pharmaceuticals purchased Nitropress and Isuprel, a pair of life-saving heart drugs. The same day…

Yesterday, Democratic Presidential candidate Hillary Clinton proposed a new plan to address pharmaceutical “price…

There is a growing movement in Congress to push the Department of Health and Human Services (HHS) to postpone Stage 3 of the…

This past month, the House of Representatives convincingly passed the 21st Century Cures Act. This bill contains…

Last week, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing on Medicare Part D …